EPIC Program Annual Data Tables 2005-2006: Table VIII
| Rank by Number of Claims | Drug and Strength | Drug Type** | Number of Claims | EPIC Payments | Rank by Payment |
|---|---|---|---|---|---|
| Top 20 Totals | 2,286,394 | $172,549,047 | |||
| Percent of Top 20 Drugs to Total Paid Claims | 19.85% | 21.22% | |||
| 1 | FUROSEMIDE (40 MG) | Gen | 171,779 | $733,478 | 195 |
| 2 | LIPITOR (10 MG) | SS | 166,260 | $17,192,756 | 5 |
| 3 | PLAVIX (75 MG) | SS | 161,754 | $28,653,466 | 1 |
| 4 | FOSAMAX (70 MG) | SS | 147,244 | $14,827,200 | 7 |
| 5 | NORVASC (5 MG) | SS | 136,209 | $8,566,206 | 12 |
| 6 | HYDROCHLOROTHIAZIDE (25 MG) | Gen | 130,927 | $430,984 | 310 |
| 7 | METOPROLOL TARTRATE (50 MG) | Gen | 121,336 | $495,058 | 270 |
| 8 | LIPITOR (20 MG) | SS | 116,196 | $17,619,069 | 4 |
| 9 | FUROSEMIDE (20 MG) | Gen | 113,674 | $438,058 | 303 |
| 10 | TOPROL XL (50 MG) | SS | 112,041 | $3,713,908 | 42 |
| 11 | PROTONIX (40 MG) | SS | 106,727 | $16,640,035 | 6 |
| 12 | NORVASC (10 MG) | SS | 103,534 | $8,527,368 | 13 |
| 13 | ATENOLOL (50 MG) | Gen | 100,342 | $572,003 | 238 |
| 14 | NEXIUM (40 MG) | SS | 97,702 | $21,126,918 | 2 |
| 15 | METFORMIN HCL (500 MG) | Gen | 95,946 | $1,644,686 | 102 |
| 16 | PREVACID (30 MG) | SS | 87,638 | $18,284,531 | 3 |
| 17 | ACTONEL (35 MG) | SS | 84,069 | $7,994,458 | 16 |
| 18 | FOLIC ACID (1 MG) | Gen | 78,198 | $560,138 | 245 |
| 19 | XALATAN (0.005%) | SS | 77,833 | $4,083,814 | 36 |
| 20 | ATENOLOL (25 MG) | Gen | 76,985 | $444,913 | 298 |
* Table VIII lists the top 20 drugs ranked by number of adjudicated claims for the program year (October 1, 2005-September 30, 2006) as well as the percentage of the totals they represent for the year.
** Drug Type values are Gen='Generic' and SS='Sole Source'.
